Last A$0.0010 AUD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:07 PM 09/8/14 All times are local (Market data is delayed by at least 15 minutes).

pharmanet group ltd (PNO) Snapshot

Open
A$0.0010
Previous Close
A$0.0010
Day High
A$0.0010
Day Low
A$0.0010
52 Week High
02/13/14 - A$0.0020
52 Week Low
09/24/13 - A$0.0010
Market Cap
2.0M
Average Volume 10 Days
50.0K
EPS TTM
A$-0.0014
Shares Outstanding
2.0B
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PHARMANET GROUP LTD (PNO)

Related News

No related news articles were found.

pharmanet group ltd (PNO) Related Businessweek News

No Related Businessweek News Found

pharmanet group ltd (PNO) Details

Pharmanet Group Limited, through its subsidiary, Molecular Pharmacology (USA) Limited, is engaged in the research, development, manufacture, and distribution of pharmaceutical products in Australia. It provides ThermaLIFE cream for use as a temporary relief from muscular skeletal and arthritic pain. The company also has licensing/partnership agreement with Dermatology Development Corp of New York to develop and market a range of cosmeceutical products. Pharmanet Group Limited is based in Leederville, Australia.

pharmanet group ltd (PNO) Top Compensated Officers

Executive Chairman and Company Secretary
Total Annual Compensation: A$72.6K
Compensation as of Fiscal Year 2013.

pharmanet group ltd (PNO) Key Developments

PharmaNet Group Ltd., Annual General Meeting, Nov 27, 2013

PharmaNet Group Ltd., Annual General Meeting, Nov 27, 2013.

PharmaNet Group Ltd. Reports Consolidated Earnings Results for the Half Year Ended December 31, 2012

PharmaNet Group Ltd. reported consolidated earnings results for the half year ended December 31, 2012. For the period, the company reported revenue of AUD 284,100 compared to AUD 24,086 a year ago. Loss before income tax was AUD 910,122 compared to AUD 1,588,526 a year ago. Loss for the period was AUD 910,122 compared to AUD 1,588,526 a year ago. Loss for the period attributable to members of the parent entity was AUD 890,481 or 0.06 cents basic and diluted per share compared to AUD 1,572,421 or 0.13 cents basic and diluted per share a year ago. Net cash flows used in operating activities was AUD 994,988 compared to AUD 1,777,561 a year ago. Payments for plant and equipment were AUD 12,307 compared to AUD 6,760 a year ago. Net tangible assets per share were 0.01 cents compared to 0.04 cents a year ago.

PharmaNet Group Ltd. to Report First Half, 2013 Results on Feb 28, 2013

PharmaNet Group Ltd. announced that they will report first half, 2013 results on Feb 28, 2013

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PNO:AU A$0.00 AUD 0.00

PNO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PNO.
View Industry Companies
 

Industry Analysis

PNO

Industry Average

Valuation PNO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.5x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMANET GROUP LTD, please visit www.pharmanet.com.au. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.